In summary, PBNK from ccRCC patients display an inhibitory profile characterized by overexpression of CD85j, CD45, CD48 and PD-1, while TINK exhibit additional alterations characterized by a decreased expression of several activating receptors. Here, LILRB1 is linked to nonpapillary renal cell carcinoma.